• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Consumer Staples

Earnings and Marriage Season

Biotech companies are saying, "I do."
By JIM CRAMER Apr 21, 2015 | 03:44 PM EDT
Stocks quotes in this article: KMB, HYH, MYL, ACT, VRX, PRGO, TEVA, VRTX, GILD, IBM

Companies that aren't supposed to beat earnings estimates. Companies that aren't supposed to be acquired. Companies that didn't go down as much as they should have on weaker earnings.

That's the story of the day even as we know each day seems to change pretty radically.

First, companies that aren't supposed to beat earnings. Kimberly Clark (KMB) put some show on with these numbers. It should have missed by a mile, but Tom Falk continues to do an amazing job with restructuring (we have a particular fondness for Halyard Health (HYH), the spinoff we own, patiently, for ActionAlertsPlus.com) Yes, KMB pulled out of the competitive part of Europe, but that doesn't mean it wasn't hurt by the dollar. Simple fact: It triumphed over the weakness and gave hope to a group people seem on the fence about. Very positive.

Mylan Labs (MYL) used to be a perennial short because there are no real barriers to entry in the generic-drug business. You put up a factory, you make knockoffs, you have low margins, and who cares? It had a history of underperforming. But these days generics are, somehow, all the rage, and so are roll-ups. Everyone wants to be Actavis (ACT)/Valeant (VRX), including Mylan with Perrigo (PRGO), and now Teva (TEVA) with Mylan. These are mergers that that no one expects, and they make the short game perilous.

Or how about the Vertex (VRTX)-Gilead (GILD) expected tie-up? The odd thing about that term is "expected." It gets floated, and then, these days, like so many other mergers, it actually comes true. That's why I wouldn't get in front of Vertex on the short side, which would be a natural normally on what can only be described -- at least in another time -- as frivolous chatter.

Finally, there's IBM (IBM). Here's  a tech company with no growth that had rallied into the print, delivered no growth and then didn't give up much of the gain it had because, it seems, there's no one left to sell it. So odd.

These are the mysteries that keep us going until something really good happens economically in China, which seems to matter so much more of late, or we bounce back in April here as we seem to be on the verge of being ready for that tightening.

Oh, and if oil stays right here, plus or minus two dollars, it's pretty much reached a natural level that makes drilling fine for good properties and the weak prey for the big. Another good sign.

Random Musings: Thanks so much for all of the kind words about our nuptials. Really quite the outpouring of goodness, and both Lisa and I thank you.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Actions Alert PLUS, which Cramer co-manages as a charitable trust, is long HYH and ACT.

TAGS: Investing | U.S. Equity | Consumer Staples | Stocks

More from Consumer Staples

General Mills Shares Have Eaten Their Wheaties

Bruce Kamich
Jul 13, 2022 9:03 AM EDT

Let's see if the strength can continue.

I'm Not Convinced PepsiCo Is Ready to Pop

Bruce Kamich
Jul 12, 2022 8:03 AM EDT

The beverage giant just posted a second-quarter earnings beat, but whether its stock can push through technical resistance remains to be seen.

3 'Hiding Places' for Investors to Shelter in This Bear Market

Stephen Guilfoyle
Jul 5, 2022 10:00 AM EDT

These stocks have done me right of late, and are in better technical shape than the market.

I'm Intrigued as Kellogg Splits Into 3: Here's the Play

Stephen Guilfoyle
Jun 21, 2022 10:15 AM EDT

The company, despite a nice looking first quarter, has not been in the greatest shape fundamentally.

Any Bounce in This Nasty Bear Market Should Be Viewed With Caution

Bob Byrne
May 11, 2022 8:30 AM EDT

For now, any rebound is a short-term trading opportunity and nothing more.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:23 PM EDT STEPHEN GUILFOYLE

    We're Cleaning Out This Retailer From the Bullpen

    Check out the latest moves in TheStreet's Stocks U...
  • 10:24 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    To Improve Your Trading and Investing, Spend More ...
  • 08:44 AM EDT PETER TCHIR

    CPI Beats Expectations, But Maybe Not the 'Whisper'?

    Slightly better-than-expected inflation across the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login